Feed morbidity-and-mortality-weekly-report-mmwr Morbidity and Mortality Weekly Report (MMWR)

Favorite IconMorbidity and Mortality Weekly Report (MMWR)

Link https://www.cdc.gov/mmwr/index.html
Feed http://www2c.cdc.gov/podcasts/createrss.asp?t=r&c=5
Updated 2024-06-02 13:03
Investigation of SARS-CoV-2 Transmission Associated With a Large Indoor Convention — New York City, November–December 2021
This report describes SARS-CoV-2 transmission at a large indoor convention among a highly vaccinated population.
SURVEILLANCE SUMMARIES: Assisted Reproductive Technology Surveillance — United States, 2018
CDC reports on assisted reproductive technology procedures performed in 2018.
Notes from the Field: Outbreak of COVID-19 Among a Highly Vaccinated Population Aboard a U.S. Navy Ship After a Port Visit — Reykjavik, Iceland, July 2021
This report describes an outbreak of Delta variant aboard a U.S. Navy ship.
QuickStats: Death Rates Attributed to Excessive Cold or Hypothermia, by Urbanization Level and Sex — National Vital Statistics System, 2018–2020
This report describes death rates attributed to excessive cold or hypothermia.
Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, July 2021–January 2022
This report describes increases in COVID-19 hospitalization rates among children and adolescents during Omicron, especially among children not yet eligible for vaccination.
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19–Associated Hospitalization in Infants Aged <6 Months — 17 States, July 2021–Janu
This report describes maternal mRNA vaccine effectiveness against COVID-19 hospitalizations among infants under 6 months of age.
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022
This report describes how local and systemic reactions and myocarditis are less frequent after a homologous COVID-19 booster dose.
EARLY RELEASE: Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Period
This report describes how vaccine effectiveness against COVID-19–associated emergency department/urgent care visits and hospitalizations was higher after the third dose but decreased with time.
Preventive Dental Care and Oral Health of Children and Adolescents With and Without Heart Conditions — United States, 2016–2019
This report describes dental care rates among children with and without heart conditions.
Identifying Higher-Volume Antibiotic Outpatient Prescribers Using Publicly Available Medicare Part D Data — United States, 2019
This report describes antibiotic prescribing rates in a peer comparison.
Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022
This report describes genomic surveillance sequencing of COVID-19 variants by jurisdiction.
QuickStats: Percentage of Children and Adolescents Aged 5–17 Years Who Reported Being Tired Most Days or Every Day, by Age Group and Hours of Screen Time — National Health Interview Survey
This report describes tiredness among children and adolescents by age and screentime.
Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination — Worldwide, 2012–2020
This report describes global progress towards rubella elimination.
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance —
This report describes how COVID-19 vaccinations and booster doses were associated with lower chances of ICU admission for hospitalized SARS-CoV-2 infected adults during Omicron predominance.
Effectiveness of Face Mask or Respirator Use in Indoor Public Settings for Prevention of SARS-CoV-2 Infection — California, February–December 2021
This report describes face mask or respirator effectiveness in helping protect against COVID-19 infection.
QuickStats: Rates of Emergency Department Visits Related to Mental Health Disorders Among Adults Aged ≥18 Years, by Disorder Category — National Hospital Ambulatory Medical Care Survey, Unite
This report describes rates of emergency department visits related to mental health disorders.
Self-Rated Physical Health Among Working-Aged Adults Along the Rural-Urban Continuum — United States, 2021
This report describes self-reported physical health among adults in both rural and urban areas of the United States.
Erratum: Vol. 70, No. 51–52
MMWR erratum volume 70, number 51–52.
Notes from the Field: COVID-19 Vaccination Among Persons Living with Diagnosed HIV Infection — New York, October 2021
This report describes COVID-19 vaccination coverage among adults diagnosed with HIV infection.
COVID-19 Vaccination Coverage and Vaccine Confidence by Sexual Orientation and Gender Identity — United States, August 29–October 30, 2021
This report describes COVID-19 vaccination coverage by sexual orientation and gender identity.
Association Between Social Vulnerability and Rates of HIV Diagnoses Among Black Adults, by Selected Characteristics and Region of Residence — United States, 2018
This report describes social vulnerability and rates of HIV diagnoses among black adults.
SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance — Los Angeles County, Califo
This report describes COVID-19 incidence and hospitalization rates during Omicron predominance in January 2022.
QuickStats: Percentage of Adults Aged ≥18 Years with Diagnosed Diabetes, by Disability Status and Age Group — National Health Interview Survey, United States, 2020
This report describes the percentage of adults with diabetes by disability status and age group.
Erratum: Vol. 71, No. 2
MMWR erratum volume 71, number 2.
Erratum: Vol. 71, No. 1
MMWR erratum volume 71, number 1.
Notes from the Field: Increased Incidence of Fentanyl-Related Deaths Involving Para-fluorofentanyl or Metonitazene — Knox County, Tennessee, November 2020–August 2021
This report describes an increasing presence of para-fluorofentanyl in emergency department patients in Knox County, Tennessee..
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — Unit
This report describes the Advisory Committee on Immunization Practice recommendations for administering the pneumococcal conjugate vaccine to U.S. adults.
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–Dece
This report describes the effectiveness of the third dose of Pfizer-BioNTech and Moderna vaccines in preventing hospitalizations.
Surveillance Summaries: Surveillance for Violent Deaths — National Violent Death Reporting System, 39 States, the District of Columbia, and Puerto Rico, 2018
This report provides a detailed summary of data from NVDRS on violent deaths that occurred in 2018.
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods — United States, December 2020–Ja
This report describes disease severity and healthcare utilization during the emergence of the Omicron variant of the virus that causes COVID-19 in the U.S.
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, Ap
This report describes COVID-19 incidence rate ratios for unvaccinated versus fully vaccinated persons with and without booster vaccine doses during the emergence of the Omicron variant.
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis — California and New York, May–November 2021
This report describes COVID-19 cases and hospitalizations by vaccination status and previous COVID-19 diagnosis before and after the Delta variant became predominant.
EARLY RELEASE: Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delt
This report describes COVID-19 vaccine effectiveness time frames among people who received their first and second doses of the vaccine series, and effectiveness of third vaccine doses during both Delta- and Omicron-predominant periods.
Surveillance Summaries: Disease Surveillance Among U.S.-Bound Immigrants and Refugees — Electronic Disease Notification System, United States, 2014–2019
This report summarizes health data reported to the Electronic Disease Notification system for refugees, immigrants, and eligible others who arrived in the United States during 2014–2019.
QuickStats: Percentage of Children Aged 2–17 Years With 2 Hours of Screen Time Per Weekday, by Sex and Age Group — National Health Interview Survey, United States, 2020
This report describes the percentage of children with more than two hours of screen time per weekday.
Notes from the Field: Early Evidence of the SARS-CoV-2 B.1.1.529 (Omicron) Variant in Community Wastewater — United States, November–December 2021
This report describes early evidence of the Omicron variant in community wastewater.
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
This report describes updated recommendations from the ACIP to the use of Janssen mRNA COVID-19 vaccines.
Progress Toward Poliomyelitis Eradication ― Afghanistan, January 2020–November 2021
This report describes a decrease in wild poliovirus type 1 during 2021 among children in Afghanistan.
Zika-Associated Birth Defects Reported in Pregnancies with Laboratory Evidence of Confirmed or Possible Zika Virus Infection — U.S. Zika Pregnancy and Infant Registry, December 1, 2015–Mar
This report describes the frequency of individual Zika-associated birth defects from the U.S. Zika Pregnancy and Infant Registry.
Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
This report describes the ACIP recommendations for two doses of RZV to prevent herpes zoster and related complications in immunocompromised adults.
Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — United States, March 2020–August 2021
This report describes racial and ethnic disparities in receiving medications for COVID-19 treatment.
Supplements: Standards Required for the Development of CDC Evidence-Based Guidelines
Guidelines for developing CDC evidence-based guidelines
Notes from the Field: HIV Outbreak During the COVID-19 Pandemic Among Persons Who Inject Drugs — Kanawha County, West Virginia, 2019–2021
This report describes a Kanawha County HIV outbreak during the COVID-19 pandemic among people who inject drugs.
Trends in Breast Cancer Incidence, by Race, Ethnicity, and Age Among Women Aged ≥20 Years — United States, 1999–2018
This report describes trends in breast cancer incidence among women.
Impact of the DREAMS Program on New HIV Diagnoses in Adolescent Girls and Young Women Attending Antenatal Care — Lesotho, 2015–2020
This report describes HIV prevalence among young women in Lesotho.
QuickStats: Percentage of Adults Aged ≥18 Years Who Received Care at Home From a Friend or Family Member in the Past 12 Months, by Sex and Age Group — National Health Interview Survey, United
This report describes the percentage of adults who received care at home from a friend or family member.
Evaluation of State-Led Surveillance of Neonatal Abstinence Syndrome — Six U.S. States, 2018–2021
This report describes an evaluation of state-led surveillance of neonatal abstinence syndrome.
Risk for Newly Diagnosed Diabetes 30 Days After SARS-CoV-2 Infection Among Persons Aged 18 years — United States, March 1, 2020–June 28, 2021
This report describes how children and adolescents were more likely to receive a new diabetes diagnosis after infection with SARS-CoV-2, the virus that causes COVID-19.
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
This report describes how effective Pfizer-BioNTech COVID-19 vaccination was against multisystem inflammatory syndrome in children (MIS-C).
Surveillance Summaries: Suicidal Thoughts and Behaviors Among Adults Aged ≥18 Years — United States, 2015–2019
2015–2019 National Survey on Drug Use and Health data regarding national-, regional-, and state-level prevalence of suicidal thoughts, planning, and attempts.
...12131415161718192021...